Sprache: Englisch
Verlag: Cham, Springer International Publishing., 2020
ISBN 10: 3030430316 ISBN 13: 9783030430313
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
2nd ed. 2020. 18 x 25 cm. XIII, 212 S. XIII, 212 p. 24 illus., 17 illus. in color. (Advances in Experimental Medicine and Biology). Sprache: Englisch.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 162,73
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 162,73
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 174,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 174,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Taschenbuch. Zustand: Neu. Current Advances in the Science of Osteosarcoma | Research Perspectives: Tumor Biology, Organ Microenvironment, Potential New Therapeutic Targets, and Canine Models | Eugenie S. Kleinerman (u. a.) | Taschenbuch | xiii | Englisch | 2021 | Springer | EAN 9783030430870 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Sprache: Englisch
Verlag: Springer International Publishing, 2021
ISBN 10: 3030430871 ISBN 13: 9783030430870
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This thoroughly revised second edition is an up-to-date overview of the new advances in the knowledge of the basic science in sarcoma and osteosarcoma. It features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, this essential volume also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists.
Sprache: Englisch
Verlag: Springer International Publishing, 2020
ISBN 10: 3030430847 ISBN 13: 9783030430849
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This thoroughly revised second edition is an up-to-date overview of the new advances in the knowledge of the basic science in sarcoma and osteosarcoma. It features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, this essential volume also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists.
Sprache: Englisch
Verlag: Springer International Publishing, 2021
ISBN 10: 3030430340 ISBN 13: 9783030430344
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This thoroughly revised second edition complied in 2 books is an up-to-date overview of the current clinical advances in sarcoma and osteosarcoma. The new edition features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, these essential volumes also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes,Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, area timely and urgently needed guide for laboratory investigators and clinical oncologists focused in sarcoma.
Sprache: Englisch
Verlag: Springer International Publishing, 2020
ISBN 10: 3030430316 ISBN 13: 9783030430313
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This thoroughly revised second edition complied in 2 books is an up-to-date overview of the current clinical advances in sarcoma and osteosarcoma. The new edition features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, these essential volumes also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes,Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, area timely and urgently needed guide for laboratory investigators and clinical oncologists focused in sarcoma.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 229,42
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 2nd edition. 246 pages. 10.00x7.01x0.52 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 231,83
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2nd edition. 233 pages. 10.00x7.00x0.75 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 242,27
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 2nd edition. 225 pages. 10.00x7.00x0.48 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 244,69
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2nd edition. 225 pages. 10.00x7.01x0.75 inches. In Stock.